U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07607925) titled 'A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL' on May 19.
Brief Summary: The goal of this clinical trial is to learn if drug GSK5926371 works to treat a form of B-cell cancer (a type of blood cancer) that has returned or failed to respond to prior therapies in adults. The study will primarily assess the drugs safety and tolerability in participants. Additionally, it seeks to determine the clinical efficacy and pharmacokinetic (PK) properties of GSK5926371.
Study Start Date: June 12
Study Type: INTERVENTIONAL
Condition:
Lymphoma, Non-Hodgkin
Intervention:
D...